PW Medtech Group Limited

HKSE 1358.HK

PW Medtech Group Limited Shares (Diluted, Weighted) for the year ending December 31, 2023: 1,565,632,000

PW Medtech Group Limited Shares (Diluted, Weighted) is 1,565,632,000 for the year ending December 31, 2023, a -0.03% change year over year. Shares (diluted, weighted) are the number of outstanding shares used to calculate earnings per share (EPS) assuming the conversion of all potentially dilutive securities.
  • PW Medtech Group Limited Shares (Diluted, Weighted) for the year ending December 31, 2022 was 1,566,123,000, a -0.20% change year over year.
  • PW Medtech Group Limited Shares (Diluted, Weighted) for the year ending December 31, 2021 was 1,569,276,000, a -0.00% change year over year.
  • PW Medtech Group Limited Shares (Diluted, Weighted) for the year ending December 31, 2020 was 1,569,310,000, a 0.00% change year over year.
  • PW Medtech Group Limited Shares (Diluted, Weighted) for the year ending December 31, 2019 was 1,569,292,000, a 0.03% change year over year.
Key data
Date Shares (Diluted, Weighted) Revenue Cost of Revenue Gross Profit
Market news
Loading...
HKSE: 1358.HK

PW Medtech Group Limited

CEO Ms. Yue'e Zhang
IPO Date Nov. 8, 2013
Location China
Headquarters Building 1
Employees 1,302
Sector Health Care
Industries
Description

PW Medtech Group Limited, an investment holding company, operates as a medical device company in the People's Republic of China. The company manufactures and sells infusion sets, such as non-PVC-based infusion sets, precision filter infusion sets, light resistant infusion sets, intravenous cannula products, and insulin needles and pens. It also provides property management services. The company was formerly known as Pyholding Limited. PW Medtech Group Limited was founded in 1997 and is headquartered in Beijing, the People's Republic of China.

Similar companies

1345.HK

China Pioneer Pharma Holdings Limited

USD 0.30

-0.02%

1349.HK

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd.

USD 0.29

2.68%

StockViz Staff

January 15, 2025

Any question? Send us an email